Please assess the completion status of the following clinical trial:

Trial Title: A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Advanced prostate cancer~* Indication to initiate androgen deprivation therapy (ADT)~* Predefined cardiovascular disease~Exclusion Criteria:~* Previous or current hormonal management of prostate cancer (unless terminated at least 12 months prior to trial)~* Acute cardiovascular disease in the previous 30 days

- Gender: MALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Degarelix (Type: EXPERIMENTAL): None
- Leuprolide (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).